Ambea Valuation
Is 6MA undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Share Price vs Fair Value
What is the Fair Price of 6MA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 6MA?
Other financial metrics that can be useful for relative valuation.
What is 6MA's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | kr5.66b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 1.2x |
Enterprise Value/EBITDA | 14x |
PEG Ratio | 0.8x |
Price to Earnings Ratio vs Peers
How does 6MA's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 25.1x | ||
RHK RHÖN-KLINIKUM | 23x | n/a | €890.3m |
M12 M1 Kliniken | 39.3x | 32.2% | €250.0m |
LIK LIMES Schlosskliniken | 31.3x | n/a | €101.4m |
JTH Gesundheitswelt Chiemgau | 6.7x | n/a | €24.4m |
6MA Ambea | 12.4x | 15.4% | €5.7b |
Price to Earnings Ratio vs Industry
How does 6MA's PE Ratio compare vs other companies in the European Healthcare Industry?
Price to Earnings Ratio vs Fair Ratio
What is 6MA's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 12.4x |
Fair PE Ratio | 28x |
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?